OS10.5.A Modeling immunocompetent tumor microenvironment in glioblastoma patient-derived orthotopic xenografts

Abstract Background To date, glioblastoma (GBM) remains a fatal disease, with a median overall survival of roughly over a year. There is a crucial need of new treatment options, yet most clinical trials have failed partly due to the lack of predictive preclinical model systems. Currently, most patie...

Full description

Saved in:
Bibliographic Details
Published inNeuro-oncology (Charlottesville, Va.) Vol. 24; no. Supplement_2; pp. ii21 - ii22
Main Authors Moreno-Sanchez, P M, Oudin, A, Yabo, Y A, Klein, E, Baus, V, Poli, A, Michelucci, A, Niclou, S P, Golebiewska, A
Format Journal Article
LanguageEnglish
Published US Oxford University Press 05.09.2022
Subjects
Online AccessGet full text

Cover

Loading…